Pancytopenia: Bone Marrow Failure and Multi-Lineage

Pancytopenia is defined as the simultaneous reduction of all three blood cell lineages: red blood cells (anemia), white blood cells (leukopenia, particularly neutropenia), and platelets (thrombocytopenia). It is not a disease itself but rather a hematological finding that reflects an underlying pathological process affecting the bone marrow's ability to produce adequate blood cells. Understanding the diverse etiologies and pathophysiological mechanisms is essential for accurate diagnosis and appropriate nursing management. Bone Marrow Failure — Aplastic Anemia: Aplastic anemia is the prototypical bone marrow failure syndrome, characterized by pancytopenia with a hypocellular (fatty) bone marrow. The pathogenesis is predominantly immune-mediated: autoreactive CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells target hematopoietic stem cells (HSCs) through oligoclonal expansion, releasing interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) that directly suppress HSC proliferation and induce HSC apoptosis through Fas-FasL interactions. The resulting depletion of the HSC pool leads to progressive marrow hypocellularity and failure of blood cell production across all lineages. Acquired aplastic anemia accounts for 80% of cases, with identified triggers including drugs (chloramphenicol, sulfonamides, phenytoin, carbamazepine, NSAIDs), toxins (benzene, pesticides), viral infections (hepatitis...